Author:
Zhuang Ze-Hao,Xie Jing-Jing,Wei Jing-Jing,Tang Du-Peng,Yang Li-Yong
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry, medical,Clinical Biochemistry,Endocrinology,Endocrinology, Diabetes and Metabolism
Reference38 articles.
1. Heading RC. Epidemiology of oesophageal reflux disease. Scand J Gastroenterol Suppl. 1989;168:33–7.
2. Zhuang ZH, Zou FM, Tang DP, Zhuang JY, Wei JJ, Yang LY. The 5-HT4 receptor agonist mosapride attenuates inflammation of reflux esophagitis. Hepatogastroenterology. 2014;61(129):115–9.
3. Richter JE. Gastrooesophageal reflux disease. Best Pract Res Clin Gastroenterol. 2007;21(4):609–31. doi: 10.1016/j.bpg.2007.03.003 .
4. Isomoto H, Saenko VA, Kanazawa Y, Nishi Y, Ohtsuru A, Inoue K, et al. Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease. Am J Gastroenterol. 2004;99(4):589–97. doi: 10.1111/j.1572-0241.2004.04110.x .
5. Monkemuller K, Wex T, Kuester D, Fry LC, Peitz U, Beyer M, et al. Interleukin-1beta and interleukin-8 expression correlate with the histomorphological changes in esophageal mucosa of patients with erosive and non-erosive reflux disease. Digestion. 2009;79(3):186–95. doi: 10.1159/000211714 .
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献